OREANDA-NEWS  On 20 October was announced, that council of JSC Grindeks approved decision of the previous Member of the Board and Director of Business Unit of Active Pharmaceutical Ingredients Vitalijs Skrivelis to return in applied science with focus on research of anti-cancer agents and biotechnological medications. Further Vitalijs Skrivelis will be also operating as a Scientific Consultant of JSC Grindeks and the main responsibility of his activities will be supervision of research projects and implementation of innovative technologies.

In compliance with the decision of Council of JSC Grindeks Finance and Administrative Director Vadims Rabрa has been elected as a Member of the Board of JSC Grindeks.

Andris Jegorovs, who previously was operating as Quality Director of JSC Olainfarm, has become Director of Business Unit of Active Pharmaceutical Ingredients of JSC Grindeks.

Sales and Marketing Director Armands Lapiтр, who previously was Marketing and Comercial Director of JSC Olainfarm, also joined the team of JSC Grindeks.